Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
M. Farquhar, M. Jacobson, C. Braun, W. Wolfman, C. Kelly, L. M. Allen & I. C. Lega. (2020) Medical and gynecological comorbidities in adult women with Turner syndrome: our multidisciplinary clinic experience. Climacteric 23:1, pages 32-37.
Read now
Read now
A. Gompel & G. Plu-Bureau. (2018) Progesterone, progestins and the breast in menopause treatment. Climacteric 21:4, pages 326-332.
Read now
Read now
P. Piette. (2018) The history of natural progesterone, the never-ending story. Climacteric 21:4, pages 308-314.
Read now
Read now
M. L’Hermite. (2017) Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use. Climacteric 20:3, pages 205-211.
Read now
Read now
J. Y. Park & K. H. Kim. (2016) A randomized, double-blind, placebo-controlled trial of Schisandra chinensis for menopausal symptoms. Climacteric 19:6, pages 574-580.
Read now
Read now
M. Ghazanfarpour, R. Sadeghi, R. Latifnejad Roudsari, I. Khorsand, T. Khadivzadeh & B. Muoio. (2016) Red clover for treatment of hot flashes and menopausal symptoms: A systematic review and meta-analysis. Journal of Obstetrics and Gynaecology 36:3, pages 301-311.
Read now
Read now
M. Ghazanfarpour, R. Sadeghi & R. Latifnejad Roudsari. (2016) The application of soy isoflavones for subjective symptoms and objective signs of vaginal atrophy in menopause: A systematic review of randomised controlled trials. Journal of Obstetrics and Gynaecology 36:2, pages 160-171.
Read now
Read now
L. Schierbeck. (2015) Primary prevention of cardiovascular disease with hormone replacement therapy. Climacteric 18:4, pages 492-497.
Read now
Read now
R. B. Machado, N. Santana, L. F. Arruda, N. Reggi, A. C. Gandolpho & S. Siani de Moraes. (2015) How can information on the risk of breast cancer and hormone therapy be better understood?. Climacteric 18:4, pages 545-550.
Read now
Read now
F. H. Comhaire & H. T. Depypere. (2015) Hormones, herbal preparations and nutriceuticals for a better life after the menopause: part II. Climacteric 18:3, pages 364-371.
Read now
Read now
F. H. Comhaire & H. T. Depypere. (2015) Hormones, herbal preparations and nutriceuticals for a better life after the menopause: part I. Climacteric 18:3, pages 358-363.
Read now
Read now
A. Gompel, R. J. Baber, T. J. de Villiers, K.-E. Huang, R. J. Santen, D. Shah, P. Villaseca & S. Shapiro. (2013) Oncology in midlife and beyond. Climacteric 16:5, pages 522-535.
Read now
Read now
M. L’Hermite. (2013) HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT. Climacteric 16:sup1, pages 44-53.
Read now
Read now
T. J. de Villiers, A. Pines, N. Panay, M. Gambacciani, D. F. Archer, R. J. Baber, S. R. Davis, A. A. Gompel, V. W. Henderson, R. Langer, R. A. Lobo, G. Plu-Bureau & D. W. Sturdee. (2013) Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 16:3, pages 316-337.
Read now
Read now
R. D. Langer, J. E. Manson & M. A. Allison. (2012) Have we come full circle – or moved forward? The Women's Health Initiative 10 years on. Climacteric 15:3, pages 206-212.
Read now
Read now
Articles from other publishers (41)
Akanksha Goyal, Pratima Gupta & David W. Sturdee. 2023. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Roger A. Lobo. 2022. Comprehensive Gynecology. Comprehensive Gynecology
255
288.e9
.
C. Yding Andersen, S. Jouhari, L. S. Mamsen & S. O. Skouby. 2022. Female and Male Fertility Preservation. Female and Male Fertility Preservation
301
310
.
Eunjung Lee, Mi Jang, Tae-Gyu Lim, Taesoo Kim, Hyunil Ha, Jeong Hoon Lee, Hee-Do Hong & Chang-Won Cho. (2020) Selective activation of the estrogen receptor-β by the polysaccharide from Cynanchum wilfordii alleviates menopausal syndrome in ovariectomized mice. International Journal of Biological Macromolecules 165, pages 1029-1037.
Crossref
Crossref
Anne Gompel. (2019) Hormones et cancers du sein. La Presse Médicale 48:10, pages 1085-1091.
Crossref
Crossref
Anne Gompel. 2019. La Ménopause en Pratique. La Ménopause en Pratique
43
49
.
Rogerio A. Lobo. 2019. Yen and Jaffe's Reproductive Endocrinology. Yen and Jaffe's Reproductive Endocrinology
322
356.e9
.
Anne Gompel. 2019. Encyclopedia of Endocrine Diseases. Encyclopedia of Endocrine Diseases
634
645
.
Talat KhadivzadehMona Najaf NajafiMasumeh GhazanfarpourMorvarid IraniFatemeh Rajab DizavandiKhatereh Shariati. (2018) Aromatherapy for Sexual Problems in Menopausal Women: A Systematic Review and Meta-analysis. Journal of Menopausal Medicine 24:1, pages 56.
Crossref
Crossref
Christy Costanian, Heather Edgell, Chris I. Ardern & Hala Tamim. (2018) Hormone therapy use in the Canadian Longitudinal Study on Aging: a cross-sectional analysis. Menopause 25:1, pages 46-53.
Crossref
Crossref
Roger A. Lobo. (2016) Hormone-replacement therapy: current thinking. Nature Reviews Endocrinology 13:4, pages 220-231.
Crossref
Crossref
Min Kyoung KimSeok Kyo SeoHee Dong ChaeKyung Joo HwangTak KimByung-Koo YoonByung Seok Lee. (2017) Perceptions of Postmenopausal Symptoms and Treatment Options among Middle-Aged Korean Women. Yonsei Medical Journal 58:3, pages 533.
Crossref
Crossref
Adalsteinn Gudmundsson, Thor Aspelund, Gunnar Sigurdsson, Tamara Harris, Lenore J. Launer, Vilmundur Gudnason & Helgi Jonsson. (2016) Long‐Term Hormone Replacement Therapy Is Associated with Low Coronary Artery Calcium Levels in a Cohort of Older Women: The Age, Gene/Environment Susceptibility—Reykjavik Study. Journal of the American Geriatrics Society 65:1, pages 200-206.
Crossref
Crossref
Margaret Warner, Bo Huang & Jan-Ake Gustafsson. (2017) Estrogen Receptor β as a Pharmaceutical Target. Trends in Pharmacological Sciences 38:1, pages 92-99.
Crossref
Crossref
David W. Sturdee. 2017. International Encyclopedia of Public Health. International Encyclopedia of Public Health
26
34
.
Susanne Schüler-Toprak, Stephan Seitz & Olaf Ortmann. (2017) Hormones and risk of breast and gynecological cancerHormone und das Risiko für Brustkrebs und gynäkologische Malignome. Der Gynäkologe 50:1, pages 43-54.
Crossref
Crossref
Roger A. Lobo, James H. Pickar, John C. Stevenson, Wendy J. Mack & Howard N. Hodis. (2016) Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause. Atherosclerosis 254, pages 282-290.
Crossref
Crossref
Vicki Hart, Susan R. Sturgeon, Nicholas Reich, Lynnette Leidy Sievert, Sybil L. Crawford, Ellen B. Gold, Nancy E. Avis & Katherine W. Reeves. (2016) Menopausal vasomotor symptoms and incident breast cancer risk in the Study of Women’s Health Across the Nation. Cancer Causes & Control 27:11, pages 1333-1340.
Crossref
Crossref
Yanlei Ji, Zhen Han, Limei Shao & Yuehuan Zhao. (2016) Ultrasound-targeted microbubble destruction of calcium channel subunit�α 1D siRNA inhibits breast cancer via G�protein-coupled receptor 30. Oncology Reports.
Crossref
Crossref
Veronika Myasoedova, Tatyana Kirichenko, Alexandra Melnichenko, Varvara Orekhova, Alessio Ravani, Paolo Poggio, Igor Sobenin, Yuri Bobryshev & Alexander Orekhov. (2016) Anti-Atherosclerotic Effects of a Phytoestrogen-Rich Herbal Preparation in Postmenopausal Women. International Journal of Molecular Sciences 17:8, pages 1318.
Crossref
Crossref
Priyanka Kushwaha, Vikram Khedgikar, Saikat Haldar, Jyoti Gautam, Fayaj A. Mulani, Hirekodathakallu V. Thulasiram & Ritu Trivedi. (2016) Azadirachta indica triterpenoids promote osteoblast differentiation and mineralization in vitro and in vivo. Bioorganic & Medicinal Chemistry Letters 26:15, pages 3719-3724.
Crossref
Crossref
Kewen Zhou, Peng Sun, Yaxing Zhang, Xinchao You, Ping Li & Tinghuai Wang. (2016) Estrogen stimulated migration and invasion of estrogen receptor-negative breast cancer cells involves an ezrin-dependent crosstalk between G protein-coupled receptor 30 and estrogen receptor beta signaling. Steroids 111, pages 113-120.
Crossref
Crossref
Georgina E. Hale & Chrisandra L. Shufelt. (2015) Hormone therapy in menopause: An update on cardiovascular disease considerations. Trends in Cardiovascular Medicine 25:6, pages 540-549.
Crossref
Crossref
Marie Pirotta, Carolyn Ee, Helena Teede, Patty Chondros, Simon French, Stephen Myers & Charlie Xue. (2014) Acupuncture for menopausal vasomotor symptoms: study protocol for a randomised controlled trial. Trials 15:1.
Crossref
Crossref
Anne Gompel. (2014) How to Prescribe MHT According to the Risk of Breast Cancer. Current Obstetrics and Gynecology Reports 3:4, pages 238-245.
Crossref
Crossref
Richard J. Santen. (2014) Menopausal hormone therapy and breast cancer. The Journal of Steroid Biochemistry and Molecular Biology 142, pages 52-61.
Crossref
Crossref
Junzhi Wang, Fang Hu, Youcheng Luo, Huajun Luo, Nianyu Huang, Fan Cheng, Zhangshuang Deng, Weiqiao Deng & Kun Zou. (2014) Estrogenic and anti-estrogenic activities of hispolon from Phellinus lonicerinus (Bond.) Bond. et sing. Fitoterapia 95, pages 93-101.
Crossref
Crossref
Amélie Véron, Sophie Blein & David G Cox. (2014) Genome-wide association studies and the clinic: a focus on breast cancer. Biomarkers in Medicine 8:2, pages 287-296.
Crossref
Crossref
Mary Salvatore, Laurie Margolies, Minal Kale, Juan Wisnivesky, Sean Kotkin, Claudia I. Henschke & David F. Yankelevitz. (2014) Breast Density: Comparison of Chest CT with Mammography. Radiology 270:1, pages 67-73.
Crossref
Crossref
Rogerio A. Lobo. 2014. Yen & Jaffe's Reproductive Endocrinology. Yen & Jaffe's Reproductive Endocrinology
308
339.e8
.
M. L'Hermite. 2014. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
H.M. Brown-Borg. 2014. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
D.W. Sturdee. 2014. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Yanwen Yao, Xiaoling Gu, Juehua Zhu, Dongmei Yuan & Yong Song. (2013) Hormone Replacement Therapy in Females Can Decrease the Risk of Lung Cancer: A Meta-Analysis. PLoS ONE 8:8, pages e71236.
Crossref
Crossref
Maria Dalamaga, Konstantinos Karmaniolas, Evangelia Papadavid, Nicolaos Pelekanos, George Sotiropoulos & Antigoni Lekka. (2013) Hyperresistinemia is associated with postmenopausal breast cancer. Menopause 20:8, pages 845-851.
Crossref
Crossref
M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson & M Wilcox. (2013) The benefits and harms of breast cancer screening: an independent review. British Journal of Cancer 108:11, pages 2205-2240.
Crossref
Crossref
Roger A. Lobo. (2013) Where Are We 10 Years After the Women's Health Initiative?. The Journal of Clinical Endocrinology & Metabolism 98:5, pages 1771-1780.
Crossref
Crossref
L Wei, Y Zhou, Q Dai, C Qiao, L Zhao, H Hui, N Lu & Q-L Guo. (2013) Oroxylin A induces dissociation of hexokinase II from the mitochondria and inhibits glycolysis by SIRT3-mediated deacetylation of cyclophilin D in breast carcinoma. Cell Death & Disease 4:4, pages e601-e601.
Crossref
Crossref
Fan Yao, Yue Fang, Bo Chen, Feng Jin & ShuBao Wang. (2013) Association between the NBS1 Glu185Gln polymorphism and breast cancer risk: a meta-analysis. Tumor Biology 34:2, pages 1255-1262.
Crossref
Crossref
Alain Fourquet, Joseph Gligorov, Anne Gompel, Jean-Marc Guinebretière, Jean-Yves Seror, Marc Spielmann, Richard Villet & Anne LesurA. Gompel. 2013. Acquis et limites en sénologie / Assets and limits in breast diseases. Acquis et limites en sénologie / Assets and limits in breast diseases
152
159
.
Irwin Goldstein. (2012) The Effects of the Women's Health Initiative on Its 10th Year Anniversary. The Journal of Sexual Medicine 9:10, pages 2479-2482.
Crossref
Crossref